US Patent Issued to Eli Lilly and Co. on Nov. 4 for "Compounds and methods targeting interleukin-19" (Indiana Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,459,997, issued on Nov. 4, was assigned to Eli Lilly and Co. (Indianapolis).

"Compounds and methods targeting interleukin-19" was invented by Richard Earl Higgs Jr. (Zionsville, Ind.), Robert John Konrad (Carmel, Ind.), Brian Jeffrey Nickoloff (Carmel, Ind.) and Robert William Siegel II (Fountaintown, Ind.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compounds and methods targeting human interleukin-19, including therapeutic antibodies, pharmaceutical compositions and diagnostic applications useful in the field of immune-mediated diseases including psoriasis, atopic dermatitis, psoriatic arthritis, bronchial asthma and di...